期刊文献+

转染外源性Fas配体基因的正常骨髓CD34^+细胞诱导U937细胞凋亡的实验研究

The Study of Apoptosis of Leukemia Cells Induced by CD34^+ Cells Transferred with Exogenous Fas Ligand
下载PDF
导出
摘要 目的:观察转染外源性FasL的CD34+细胞对白血病细胞系U937的凋亡诱导作用,探讨通过向CD34+细胞转染FasL以增强移植后GVL效应的可能性。方法:免疫磁珠法分选骨髓CD34+细胞并进行体外扩增培养;FasL基因逆转录病毒途径转染CD34+细胞,并与白血病细胞U937混合培养,加入或不加入柔红霉素、阿糖胞苷,借助TUNEL、流式细胞仪检测细胞的凋亡率。结果:逆转录病毒上清转染后48~72h,流式细胞仪检测24.2%±2.4%CD34+细胞表达FasL(P<0.01)(未转染的CD34+细胞FasL阳性率为7.6%±1.1%)。未转染或转染外源FasL的CD34+细胞与白血病细胞U937以1:1的比例混合培养18h后,细胞凋亡率分别为5.0%±1.3%、10.8%±0.6%(P<0.01);FasL+CD34++DNR或FasL+CD34++Arac作用后,细胞凋亡率分别为13.4%±1.0%(P<0.05)、17.95%±1.3%(P<0.01)。结论:表达外源性FasL的骨髓CD34+细胞可诱导白血病细胞U937凋亡。提示植入转染外源性FasL基因的骨髓CD34+细胞可增强BMT后的GVL效应。 Objective: To assess the value of CD34+ cells transferred exogenous Fas ligand in inducing the apotosis of U937 cells. Methods: The CD34+ cells transfected with FasL or not- was mixed with leukaemic cells U937 with presence or absence of DNR or Ara-C. After18h- apoptosis of cells was detected by TUNEL and FCM. Results: Induced for 18h by CD34+ cells transfected with FasL or not- the ratio of apoptosis of U937 was 10.8%±0.6% (P<0.01)? 5.0%±1.3% respectively. Induced by FasL+CD34++DNR? FasL+ CD34++Arac- that was 13.4%±1.0% (P<0.05)? 17.9%±1.3% (P<0.01). Conclusion: CD34+ cells that was transfected with exogenous Fas ligand could induce apoptosis of human leukaemic cells- suggesting it was possible to enhance the graft-versus-leukemia effect by transplanting CD34+ cells transferred exogenous Fas ligand.
作者 刘忠文 邹萍
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2004年第13期725-728,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:39770767)
关键词 FAS配体 CD34^+细胞 调亡 U937细胞 Fas ligand CD34^+ cells Apoptosis U937 cell
  • 相关文献

参考文献11

  • 1Mcgahon AJ,Costa Pereira AP,Daly I,et al.Chemotherapeutic drug-induced apoptosis in human leukemia cells is independent of the Fas (Apo-1/CD95) receptor/ligand system[J].BrJ Haematol,1998,101(3): 539-547
  • 2Eischen CM,Kottke TJ,Martins LM,et al.Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions [J].Blood,1997,90(3): 935-943
  • 3Landowski TH,Shain KH,Oshiro MM,et al.Myeloma cells selcted for resistence to CD95-mediated apoptosis are not crossresistant to cytotoxic drugs: evidence for independent mechamsms of caspase activation[J].Blood,1999,94(1): 265~274
  • 4Cullen KV,Davey RA,Davey MW,et al.Drug resistance does not correlate with resistance to Fas-mediated apoptosis [J].Leuk Res,2001,25(1): 69-75
  • 5Oconnell J,Gerald C,Osullivan,et al.The Fas counter-attack:Fas-mediated T cell killing by colon cancer cells expressing fas ligand[J].J Exp Med,1996,184(3): 1075-1082
  • 6Wieder T,Essmann F,Prokop A,et al.Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3[J].Blood,2001,97(5): 1378~1387
  • 7Los M,Herr I,Friesen C,et al.Cross-resistance of CD95-and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)[J].Blood,1997,90(8): 3118-3129
  • 8Findley HW,Zhou M.The clinical significance of Fas expression in leukemia: questions and controversies [J].Leukemia,1999,13(2): 147-149
  • 9刘忠文,肖娟,游泳,邹萍.化疗药物诱导白血病细胞凋亡对Fas/FasL途径依赖性的研究[J].中华血液学杂志,2002,23(1):39-40. 被引量:6
  • 10Williams JF,Petrus MJ,Wright JA,et al.fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type Ⅰ versus type Ⅱ cytokines and autologous fasL-expressing T cells[J].Br J Haematol,1999,107(1): 99-105

二级参考文献18

  • 1王立生,裴雪涛,吴祖泽.造血细胞体外扩增的研究进展及应用前景[J].中华血液学杂志,1995,16(8):441-443. 被引量:6
  • 2裴雪涛,吴祖泽.利用吸附单克隆抗体-磁珠分离系统分离CD_(34)^+造血祖细胞[J].中华血液学杂志,1995,16(5):270-271. 被引量:15
  • 3Champlin R. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation. Hematol Oncol Clin North Am,1990; 4:687-698
  • 4Lau HT, Yu M, Fontana A, et al. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science,1996; 273:109 - 112
  • 5Wickelgren I. Muscling transplants into mice. Science, 1996; 273:33
  • 6Hatzfeld A, Batard P, Panteme B, et al. Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescenee. Hum Gene Ther, 1996; 7: 207- 213
  • 7O'Connell J, O'Sullivan GC, Collins JK, et al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med, 1996; 184:1075 - 1082
  • 8Suda T, Hashimoto H, Tanaka M, et al. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med, 1997; 186:2045- 2050
  • 9Spinozzi F, Agea E, Fizzotti M, et al. Role of T-helper type 2 cytokines in down-modulation of fas mRNA and receptor on the surface of activated CD4( + ) T cells: molecular basis for the persistence of the allergic immune response. FASEB J, 1998; 12:1747 - 1753
  • 10Nagafuji K, Shibuya T, Harada M, et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood,1995; 86: 883 - 889

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部